Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
InterBioScreen
Chernogolovka, Moscow Region, Russiaibscreen.com ↗
- Ownership
- Private
- Employees
- ~200
- Development stage
- Other
01
Overview
InterBioScreen provides vast and diverse libraries of synthetic and natural compounds for drug screening and discovery. It does not develop clinical drugs itself, but enables preclinical discovery for pharma, biotech, and academic partners globally. There are no reported clinical-stage assets.
- Modalities
- Small moleculeNatural productSynthetic compound
- Industry
- Drug Discovery Services
Beyond the preview
Go deeper on InterBioScreen.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on InterBioScreen.